Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.
Puri
V
V
Department of Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, Minnesota 55905-0001, USA.
Watanabe
R
R
Dominguez
M
M
Sun
X
X
Wheatley
C L
CL
Marks
D L
DL
Pagano
R E
RE
D001692:Biological Transport; D001896:Boron Compounds / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism*; D004705:Endocytosis / Q000502:physiology*; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D005456:Fluorescent Dyes / Q000378:metabolism; D016537:Gangliosidosis, GM1 / Q000378:metabolism; D006801:Humans; D009542:Niemann-Pick Diseases / Q000378:metabolism; D013106:Sphingolipidoses / Q000378:metabolism*; D013107:Sphingolipids / Q000378:metabolism*
C095489:4,4-difluoro-4-bora-3a,4a-diaza-s-indacene; D001896:Boron Compounds; D005456:Fluorescent Dyes; D013107:Sphingolipids; D002784:Cholesterol